Department of Cancer Biology, University of Massachusetts Medical School, 364 Plantation Street-LRB 411, Worcester, MA 01605, USA.
J Oncol. 2011;2011. doi: 10.1155/2011/396076. Epub 2010 Sep 29.
Long-lived cancer stem cells (CSCs) with indefinite proliferative potential have been identified in multiple epithelial cancer types. These cells are likely derived from transformed adult stem cells and are thought to share many characteristics with their parental population, including a quiescent slow-cycling phenotype. Various label-retaining techniques have been used to identify normal slow cycling adult stem cell populations and offer a unique methodology to functionally identify and isolate cancer stem cells. The quiescent nature of CSCs represents an inherent mechanism that at least partially explains chemotherapy resistance and recurrence in posttherapy cancer patients. Isolating and understanding the cell cycle regulatory mechanisms of quiescent cancer cells will be a key component to creation of future therapies that better target CSCs and totally eradicate tumors. Here we review the evidence for quiescent CSC populations and explore potential cell cycle regulators that may serve as future targets for elimination of these cells.
在多种上皮癌类型中已经鉴定出具有无限增殖潜力的长寿癌干细胞(CSC)。这些细胞可能来自于转化的成体干细胞,并且被认为与它们的亲本群体具有许多共同特征,包括静止的慢周期表型。已经使用了各种标记保留技术来鉴定正常的慢周期成体干细胞群体,并提供了一种独特的方法来功能上鉴定和分离癌干细胞。CSC 的静止性质代表了一种内在机制,至少部分解释了化疗耐药性和治疗后癌症患者的复发。分离和理解静止癌细胞的细胞周期调控机制将是未来治疗的关键组成部分,这些治疗将更好地靶向 CSC 并完全根除肿瘤。在这里,我们回顾了关于静止 CSC 群体的证据,并探讨了可能作为消除这些细胞的未来靶点的潜在细胞周期调节剂。